Technical Analysis for ADPT - Adaptive Biotechnologies Corporation

Grade Last Price % Change Price Change
F 43.68 -12.92% -6.48
ADPT closed down 12.92 percent on Thursday, March 4, 2021, on 2.24 times normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical ADPT trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Reached Oversold Weakness -12.92%
Older End-of-Day Signals for ADPT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 10% about 7 hours ago
Down 1 ATR about 9 hours ago
60 Minute Opening Range Breakdown about 9 hours ago
Rose Above Lower Bollinger Band about 10 hours ago
2x Volume Pace about 10 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Adaptive Biotechnologies Corporation Description

Adaptive Biotechnologies Corporation develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer research questions that inform current and future clinical trials, as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ diagnostic tests, which include immunosequencing services for use in the detection and monitoring of minimal residual disease in patients with select blood cancers. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. It serves the life sciences research, clinical diagnostics, and drug discovery customers. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was founded in 2009 and is headquartered in Seattle, Washington.


Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Diseases Infectious Diseases Cancers Drug Discovery Diagnostic Tests Leukemia Blood Test Treatment Of A Range Of Cancer Blood Cancers Such As Cancer Clinical Products Residual Disease

Is ADPT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 71.25
52 Week Low 15.19
Average Volume 819,903
200-Day Moving Average 48.92
50-Day Moving Average 60.36
20-Day Moving Average 58.86
10-Day Moving Average 55.18
Average True Range 4.00
ADX 22.04
+DI 16.43
-DI 41.79
Chandelier Exit (Long, 3 ATRs ) 55.33
Chandelier Exit (Short, 3 ATRs ) 55.50
Upper Bollinger Band 69.44
Lower Bollinger Band 48.29
Percent B (%b) -0.22
BandWidth 35.92
MACD Line -2.76
MACD Signal Line -1.13
MACD Histogram -1.634
Fundamentals Value
Market Cap 5.97 Billion
Num Shares 137 Million
EPS -4.34
Price-to-Earnings (P/E) Ratio -10.06
Price-to-Sales 67.84
Price-to-Book 8.63
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 53.98
Resistance 3 (R3) 55.06 52.70 52.26
Resistance 2 (R2) 52.70 50.08 52.16 51.69
Resistance 1 (R1) 48.19 48.46 47.02 47.11 51.12
Pivot Point 45.84 45.84 45.25 45.30 45.84
Support 1 (S1) 41.33 43.22 40.15 40.25 36.24
Support 2 (S2) 38.97 41.60 38.43 35.67
Support 3 (S3) 34.46 38.97 35.10
Support 4 (S4) 33.38